Neuroprotective effects of herbal ethanol extracts from gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of parkinson's disease

Molecules

Volumn 15, Issue 4, 2010, Pages 2814-2824

  Choi, Hyun Sook ^a   Park, Mi Sook ^a   Kim, Seung Hwan ^b   Hwang, Bang Yeon ^a   Lee, Chong Kil ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

6 hydroxydopamine lesioned rats; Dopamine; Gynostemma pentaphyllum; Parkinson's disease; Tyrosine Hydroxylase

Indexed keywords

ALCOHOL; NEUROPROTECTIVE AGENT; OXIDOPAMINE; PLANT EXTRACT; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; CELL DEATH; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GYNOSTEMMA; MALE; METABOLISM; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; ETHANOL; GYNOSTEMMA; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 77951778439     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15042814     Document Type: Article

References (34)

1. Neil, A.; David, B. Parkinson's disease. Medicine 2008, 36, 630-635.
2. Hornykiewicz, O. Imbalance of Brain monoamines and clinical disorders. Prog. Brain Res. 1982, 55, 419-429.
3. Marsden, C.D. Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1994, 57, 672-681.
4. Jankovic, J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov. Disord. 2005, 20, S11-S16. (Pubitemid 40846906)
5. Perese, D.A.; Ulman, J.; Viola, J.; Ewing, S.E.; Bankiewicz, K.S. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res. 1989, 494, 285-293. (Pubitemid 19194542)
6. Schober, A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004, 318, 215-224. (Pubitemid 39366054)
7. Slater, T.F. Free-radical mechanisms in tissue injury. Biochem. J. 1984, 15, 1-15.
8. Fahn, S.; Cohen, G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 1992, 32, 804-812.
9. Cadet, J.L.; Brannock, C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 1998, 32, 117-131. (Pubitemid 28105298)
10. Maharaj, H.; Sukhdev, M,D.; Scheepers, M.; Mokokong, R.; Daya, S. L-DOPA administration enhances 6-hydroxydopamine generation. Brain Res. 2005, 1063, 180-186. (Pubitemid 41741029)
11. Razmovski-Naumovski, V.; Huang, T.H-.W.; Tran, V.H.; Li, G.Q.; Duke, C.C.; Roufogalis, B.D. Chemistry and pharmacology of Gynostemma Pentaphyllum. Phytochem. Rev. 2005, 4, 197-219.
12. Choi, H.S.; Lim, S.A.; Park, M.S.; Hwang, B.Y.; Lee, C.K.; Kim, S.H.; Lim, S.C.; Lee, M.K. Ameliorating effects of the ethanol extracts from Gynostemma Pentaphyllum on electric footshock stress. Kor. J. Pharmacogn. 2008, 39, 341-346.
13. Im, S.A.; Choi, H.S.; Hwang, B.Y.; Lee, M.K.; Lee, C.K. Augmentation of Immune Responses by oral administration of Gynostemma Pentaphyllum ethanol extract. Kor. J. Pharmacogn. 2009, 40, 35-40.
14. Nagai, M.; Izawa, K.; Nagumo, S.; Sakurai, N.; Inoue, T. Two glycosides of a novel dammarane alcohol from Gynostemma Pentaphyllum. Chem. Pharm. Bull. 1981, 29, 779-783. (Pubitemid 11124664)
15. Takemoto, T.; Arihara, S.; Yoshikawa, K.; Kawasaki, J.; Nakajima, T.; Okuhira, M. Studies on the constituents of Cucurbitaceae plants. XI. On the saponin constituents of Gynostemma pentaphyllum MAKINO. (7). Yakugaku Zasshi 1984, 104, 1043-1049. (Pubitemid 15190752)
16. Yoshikawa, K.; Arimitsu, M.; Kuki, K.; Takemoto, T.; Arihara, S. Studies on the constituents of Cucurbitaceae plants. XVIII. On the saponin constituents of Gynostemma pentaphyllum MAKINO. (13). Yakugaku Zasshi 1987, 107, 361-366. (Pubitemid 17097440)
17. Ren, T.; Sagar, S.M. Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res. Bull. 1992, 29, 589-597.
18. Attawish, A.; Chivapat, S.; Phadungpat, S.; Bansiddhi, J.; Techadamrongsin, Y.; Mitrijit, O.; Chaorai, B.; Chavalittumrong, P. Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia 2004, 75, 539-551. (Pubitemid 39209435)
19. Lin, J.M.; Lin, C.C.; Chiu, H.F.; Yang, J.J.; Lee, S.G. Evaluation of the anti-inflammatory and liver-protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am. J. Chin. Med. 1993, 21, 59-69.
20. Huang, W.C.; Kuo, M.L.; Li, M.L.; Yang, R.C.; Liou, C.J.; Shen, J.J. The extract of Gynostemma pentaphyllum enhanced the production of antibodies and cytokines in mice. Yakugaku Zasshi 2007, 127, 889-896.
21. Wang, Z.J.; Luo, D.H. Antioxidant activities of different fractions of polysaccharide purified from Gynostemma pentaphyllum Makino. Carbohyd. Polym. 2007, 68, 54-58.
22. Shang, L.; Liu, J.; Zhu, Q.; Zhao, L.; Feng, Y.; Wang, X.; Cao, W.; Xin, H. Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity. Brain Res. 2006, 1102, 163-174. (Pubitemid 44092666)
23. Curtius, H.C.; Wolfensberger, M.; Steinmann, B.; Redweik, U.; Siegfried, J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J. Chromatogr. 1974, 99, 529-540.
24. Severson, J.A.; Marcusson, J.; Winblad, B.; Finch, C.E. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 1982, 39, 1623-1631. (Pubitemid 13184139)
25. Linert, W.; Herlinger, E.; Jameson, R.F.; Kienzl, E.; Jellinger, K.; Youdim, M.B. Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson's disease. Biochim. Biophys. Acta 1996, 1316, 160-168. (Pubitemid 26273700)
26. Napolitano, A.; Pezzella, A.; Prota, G. New reaction pathways of dopamine under oxidative stress conditions: nonenzymatic iron-assisted conversion to norepinephrine and the neurotoxins 6-hydroxydopamine and 6,7- dihydroxytetrahydroisoquinoline. Chem. Res. Toxicol. 1999, 12, 1090-1097.
27. Basma, A.N.; Morris, E.J.; Nicklas, W.J.; Geller, H.M. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 1995, 64, 825-832.
28. Cheng, N.N.; Maeda, T.; Kume, T.; Kaneko, S.; Kochiyama, H.; Akaike, A.; Goshima, Y.; Misu, Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 1996, 743, 278-283. (Pubitemid 27028782)
29. Yacoubian, T.A.; Standaert, D.C. Targets for neuroprotection in Parkinson's disease. Biochim. Biophys. Acta 2009, 1792, 676-687.
30. Myllylä, V.V.; Sotaniemi, K.A.; Vuorinen, J.A.; Heinonen, E.H. Selegiline as initial treatment in de novo parkinsonian patients. Neurology 1992, 42, 339-343.
31. Przedborski, S.; Levivier, M.; Jiang, H.; Ferreira, M.; Jackson-Lewis, V.; Donaldson, D.; Togasaki, D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 1995, 67, 631-647.
32. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates, 2nd ed.; Academic Press: Tokyo, Australia, 1986.
33. Hudson, J.L.; van Horne, C.G.; Strömberg, I.; Brock, S.; Clayton, J.; Masserano, J.; Hoffer, B.J.; Gerhardt, G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 1993, 626, 167-174. (Pubitemid 23306825)
34. Tariq, M.; Khan, H.A.; Al Moutaery, K.; Al Deeb, S. Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents. Brain Res. Bull. 2001, 54, 77-82. (Pubitemid 32156918)